Exane Derivatives’s ChargePoint CHPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$539K Buy
1,967
+276
+16% +$76.5K 0.31% 76
2022
Q1
$672K Buy
1,691
+367
+28% +$113K 0.19% 140
2021
Q4
$505K Sell
1,324
-439
-25% -$195K 0.12% 176
2021
Q3
$705K Buy
1,763
+793
+82% +$369K 0.17% 131
2021
Q2
$506K Buy
+970
New +$514K 0.11% 179

Other funds holding CHPT

Exane Derivatives's CHPT Position: Q2 2022 in Review

Exane Derivatives increased its ChargePoint (CHPT) stake by 16% in Q2 2022, buying an estimated $76.5K and bringing the position to 1,967 shares worth $539K. The position accounts for 0.31% of the portfolio, ranked #76.

Exane Derivatives first reported a position in CHPT in Q2 2021 and has held it in 5 quarters since. The position peaked at $705K in Q3 2021. 364 funds tracked by Wall St. Rank hold CHPT as of Q2 2022.

  • Exane Derivatives held 1,967 shares of ChargePoint worth $539K as of Q2 2022.
  • Exane Derivatives bought 276 ChargePoint shares in Q2 2022, an estimated $76.5K.
  • ChargePoint made up 0.31% of Exane Derivatives's portfolio in Q2 2022, its #76 holding.
  • Exane Derivatives first reported a position in ChargePoint in Q2 2021 and has held it in 5 quarters since.
  • Exane Derivatives's ChargePoint position peaked at $705K in Q3 2021.
  • 364 funds tracked by Wall St. Rank held ChargePoint as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.